Ligand Pharmaceuticals

Ligand Pharmaceuticals

Yahoo Finance • 2 days ago

Ligand Pharmaceuticals Highlights XOMA-Fueled Royalty Growth, $700M in Deployable Capital

Key Points Interested in Ligand Pharmaceuticals Incorporated? Here are five stocks we like better. XOMA acquisition doubled Ligand's portfolio to more than 220 partnered programs, adding seven commercial-stage assets, 14 late-stage progra... Full story

Yahoo Finance • 14 days ago

Ligand Pharmaceuticals (LGND) Stock Trades Below Fair Value Following A 337% Run

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Ligand Pharmaceuticals stock has surged over the past five years, yet the valuation signals are split, with a Discounted Ca... Full story

Yahoo Finance • 15 days ago

Ligand (LGND) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Head of Investor Relations - Melanie HermanChief Executive Officer - Todd DavisChief Financial Officer - Octavio EspinozaVice President of Por... Full story

Yahoo Finance • 22 days ago

This Biotech Dealmaker — Tied To Merck, Travere — Is In A Profit-Taking Zone

Ligand stock landed in a profit-taking zone Thursday on a strong second-quarter report and an earnings guidance hike. Continue Reading... Full story

Yahoo Finance • last month

This Stock Of The Day Rides Big Pharma Royalties; It's Up 56% In 2026

LGND stock has risen more than 56.5% so far in 2026. Ligand doesn't make drugs; it forks over funding in exchange for Big Pharma royalties. Continue Reading... Full story

Yahoo Finance • 2 months ago

Agenus shares surge as company secures up to $340M to advance colon cancer trial

Agenus shares surge as company secures up to $340M to advance colon cancer trial Proactive uses images sourced from Shutterstock Agenus (Agenus Inc (NASDAQ:AGEN)) shares jumped about 100% on Monday after the biotechnology company announce... Full story

Yahoo Finance • 2 months ago

Agenus Shares Rise After Securing Up to $340 Million Financing Package (AGEN)

Stock chart with green arrow moving up ©Adobe Stock Images Private Placement Strengthens Funding Position Agenus Inc. (NASDAQ:AGEN) shares climbed 13% in premarket trading on Monday after the biotechnology company announced an $85 millio... Full story

Yahoo Finance • 2 months ago

CRISPR Therapeutics vs. Viking Therapeutics: Is a Gene-Editing or Weight Loss Focused Stock Is a Better Buy in 2026?

Key Points CRISPR Therapeutics AG has successfully launched Casgevy, the first FDA-approved CRISPR-based gene therapy. Viking Therapeutics is a development-stage company in the high-growth obesity drug market with a promising clinical pip... Full story

Yahoo Finance • 2 months ago

CRISPR Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?

Key Points CRISPR Therapeutics has transitioned to the commercial stage with the first approved CRISPR-based gene therapy. Viking Therapeutics maintains a high-potential pipeline focused on the rapidly expanding obesity and metabolic diso... Full story

Yahoo Finance • 2 months ago

Ligand Prices Upsized $625 Million Convertible Senior Notes Offering

(RTTNews) - Ligand Pharmaceuticals Incorporated (LGND) announced the pricing of an upsized $625 million offering of 0.0% convertible senior notes due 2031 in a private placement to qualified institutional buyers, strengthening the company'... Full story

Yahoo Finance • 2 months ago

Ligand Announces Pricing of Upsized $625 Million Convertible Senior Notes Offering

Opportunistic capital raise with proceeds used to enhance financial flexibility A portion of the proceeds to be used to purchase call spreads and to fund concurrent share repurchase intended to offset potential dilution to Ligand’s common... Full story

Yahoo Finance • 2 months ago

Stocks Mostly Lower on Weakness in Megacap Tech and Software Stocks

The S&P 500 Index ($SPX) (SPY) on Monday closed down -0.37%, the Dow Jones Industrial Average ($DOWI) (DIA) closed up +0.29%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -0.19%.  September E-mini S&P futures (ESU26) fell -0.34%, and... Full story

Yahoo Finance • 2 months ago

Stocks Erase Early Gains as Alphabet and Software Companies Fall

The S&P 500 Index ($SPX) (SPY) today is down -0.40%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.27%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.30%.  September E-mini S&P futures (ESU26) are down -0.38%, and September E... Full story

Yahoo Finance • 2 months ago

Stocks Supported by Strength in Chipmakers and AI-Infrastructure Stocks

The S&P 500 Index ($SPX) (SPY) today is up +0.21%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.54%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.50%.  September E-mini S&P futures (ESU26) are up +0.20%, and September E-mini... Full story

Yahoo Finance • 2 months ago

Ligand prices proposed $550M convertible senior notes offering

* Ligand Pharmaceuticals (LGND [https://seekingalpha.com/symbol/LGND]) said [https://seekingalpha.com/pr/20558475-ligand-announces-proposed-offering-of-550-million-of-convertible-senior-notes-due-2031] on Monday it plans to offer $550M o... Full story

Yahoo Finance • 2 months ago

Ligand Pharmaceuticals Reaches Analyst Target Price

In recent trading, shares of Ligand Pharmaceuticals Inc (Symbol: LGND) have crossed above the average analyst 12-month target price of $184.28, changing hands for $184.49/share. When a stock reaches the target an analyst has set, the anal... Full story

Yahoo Finance • 3 months ago

Stock Market Today: Nasdaq, Dow Knocked Down As Techs Sell Off; Cracker Barrel Surges (Live Coverage)

Stock Market Today: The Dow Jones index sinks 500 points Wednesday on Trump's comments. The CPI inflation rate hits 4.2% annually. Continue Reading... Full story

Yahoo Finance • 3 months ago

Ligand Announces 2026 Investor Day in New York City

JUPITER, Fla., June 10, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will host an Investor Day in New York City on Tuesday, December 8, 2026 at 10:30 a.m. Eastern time at the Harvard... Full story

Yahoo Finance • 3 months ago

A Ligand Pharmaceuticals (LGND) Insider Sold 5,000 Shares for $1.1 Million

Key Points 5,000 shares were sold for a total transaction value of ~$1.14 million on June 1, 2026, at a weighted average price around $227.06 per share. This sale represented 10.78% of Andrew Reardon's direct Common Stock holdings, reduci... Full story

Yahoo Finance • 3 months ago

Wealth Manager Sells $7 Million of Establishment Labs After Massive Gains. Is This Medical Device Stock a Buy?

On May 15, 2026, Rice Hall James & Associates reported selling 102,885 shares of Establishment Labs(NASDAQ:ESTA), an estimated $7.03 million transaction based on quarterly average pricing. What happened According to the SEC filing dated... Full story